Phase II trial of radiotherapy plus Huachansu in elderly or chemotherapy-ineligible patients with locally advanced esophageal squamous cell carcinoma
Compared with radiotherapy alone, concurrent radiotherapy with Huachansu injection did not improve the locoregional control rate or survival rate in elderly patients or chemotherapy-ineligible patients with locally advanced ESCC. The trial is registered with ClinicalTrials.org, NCT02647125.
Authors
- Qi Liu (ORCID: https://orcid.org/0000-0002-1560-2544)
- Dashan Ai (ORCID: https://orcid.org/0000-0002-2599-8861)
- Kuaile Zhao (ORCID: https://orcid.org/0000-0001-8663-2874)
- Shengnan Hao (ORCID: https://orcid.org/0000-0002-0640-2073)
- Yun Chen (ORCID: https://orcid.org/0000-0002-4975-5637)
- Hui Luo (ORCID: https://orcid.org/0000-0002-6164-6898)
- Jialiang Zhou (ORCID: https://orcid.org/0000-0002-6019-9192)
- Jingyi Shen (ORCID: https://orcid.org/0009-0009-6223-069X)
- Jiaying Deng (ORCID: https://orcid.org/0000-0002-1744-1203)
- Hongcheng Zhu (ORCID: https://orcid.org/0000-0001-7444-5123)
Institutions
- Jiangnan University (CN)
- Shanghai Medical College of Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Jiangxi Provincial Cancer Hospital (CN)
- Wuxi Fourth People's Hospital (CN)
- Shanghai Clinical Research Center (CN)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-09-28
- DOI
- https://doi.org/10.1093/oncolo/oyaf325
- Citations
- 2
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.70
Funders
- National Natural Science Foundation of China